title: Report of the 13th Annual International Pachyonychia Congenita Consortium Symposium.
abstract: The International Pachyonychia Congenita Consortium (IPCC) is a group of physicians and scientists from around the world dedicated to developing therapies for pachyonychia congenita, a rare autosomal dominant skin disorder. The research presented at the 13th Annual Research Symposium of the IPCC, held on 10-11 May 2016, in Scottsdale, AZ, U.S.A., is reported here.
authors.affiliation: Department of Dermatology, University of Michigan Medical School, Ann Arbor, MI, U.S.A.
authors.forename: L
authors.initials: L
authors.lastname: Rittié
authors.affiliation: TransDerm Inc., 2161 Delaware Ave, Santa Cruz, CA, 95060, U.S.A.
authors.forename: R L
authors.initials: RL
authors.lastname: Kaspar
authors.affiliation: Department of Dermatology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
authors.forename: E
authors.initials: E
authors.lastname: Sprecher
authors.affiliation: Pachyonychia Congenita Project, Salt Lake City, UT, U.S.A.
authors.forename: F J D
authors.initials: FJD
authors.lastname: Smith